"At GenesisCare, we offer multidisciplinary personalised cancer treatments based on the needs of our patients as individuals.We’re an organisation with a local, national and global presence, providing care where it’s needed. Our radiation and medical oncologists are among the world’s leading specialists in the treatment of cancer. We invest in innovative treatments, advanced technologies and clinical trials with the goal to continually improve patient outcomes. Our services include rapid diagnostic pathways, radiation oncology, medical oncology and theranostics."

During the past decade, GenesisCare Cambridge conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GenesisCare Cambridge" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "GenesisCare Cambridge" are "Chronic Lymphocytic Leukemia" (1 trials), "Lymphoma, Mantle-Cell" (1 trials) and "Small Lymphocytic Lymphoma" (1 trials). Many other conditions were trialed in "GenesisCare Cambridge" in a lesser frequency.

Most popular intervention types in "GenesisCare Cambridge" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Acalabrutinib" (1 trials), "Bendamustine" (1 trials), "Ibrutinib" (1 trials), "Idelalisib" (1 trials) and "LOXO-305" (1 trials). Other intervention names were less common.

The vast majority of trials in "GenesisCare Cambridge" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GenesisCare Cambridge". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in GenesisCare Cambridge, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GenesisCare Cambridge, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".